首页 > 最新文献

Personalized Medicine in Psychiatry最新文献

英文 中文
Cognitive control circuit function predicts antidepressant outcomes: A signal detection approach to actionable clinical decisions 认知控制回路功能可预测抗抑郁治疗效果:可操作临床决策的信号检测方法
Pub Date : 2024-04-30 DOI: 10.1016/j.pmip.2024.100126
Leanne M. Williams , Jerome Yesavage

Background

We previously identified a cognitive biotype of depression characterized by dysfunction of the brain’s cognitive control circuit, comprising the dorsolateral prefrontal cortex (dLPFC) and dorsal anterior cingulate cortex (dACC), derived from functional magnetic resonance imaging (fMRI). We evaluate these circuit metrics as personalized predictors of antidepressant remission.

Methods

We undertook a secondary analysis of data from the international Study to Predict Optimized Treatment in Depression (iSPOT-D) for 159 patients who completed fMRI during a GoNoGo task, 8 weeks treatment with one of three study antidepressants and who were assessed for remission status (Hamilton Depression Rating Scale score of ≤ 7). Circuit predictors of remission were dLPFC and dACC activity and connectivity quantified in standard deviations. Using established software implementing receiver operating analysis (ROC) we calculated the sensitivity and specificity of these predictors at every cut-point for every circuit measure. We calculated number needed to treat (NNT) metrics for the ROC model identifying optimal cut-point values.

Results

ROC models identified maximum separation of remitters (62.5%) from non-remitters (21.2%) at an initial cut-point of −0.75 standard deviations for dLPFC activity and averaged circuit metrics at secondary cutpoints. The NNT was 3.72, implying that if 4 patients (rounding of 3.72) were randomly selected, one would be likely to remit, but if circuit metrics informed treatment, two would be likely to remit.

Conclusions

Our findings contribute to identifying clinically actionable circuit measures for clinical trials and clinical practice. Future studies are needed to replicate these findings and expand the assessment of longer-term outcomes.

背景我们之前通过功能磁共振成像(fMRI)发现了一种抑郁症认知生物型,其特征是大脑认知控制回路功能障碍,该回路由背外侧前额叶皮层(dLPFC)和背侧前扣带回皮层(dACC)组成。我们对 "预测抑郁症优化治疗国际研究"(iSPOT-D)的数据进行了二次分析,这些数据来自159名患者,他们在GoNoGo任务中完成了fMRI,接受了8周三种研究抗抑郁药中一种的治疗,并被评估为缓解状态(汉密尔顿抑郁量表评分≤7分)。缓解的回路预测因子是以标准偏差量化的 dLPFC 和 dACC 活动和连通性。我们使用成熟的接收器操作分析(ROC)软件,计算了这些预测指标在每个切点对每个回路测量的敏感性和特异性。结果ROC模型确定了在dLPFC活动的初始切点-0.75标准差和次级切点的平均回路指标时,缓解者(62.5%)与非缓解者(21.2%)的最大分离率。NNT为3.72,这意味着如果随机选择4名患者(3.72的四舍五入),其中1名患者的病情有可能得到缓解,但如果以回路指标作为治疗依据,则有2名患者的病情有可能得到缓解。未来的研究需要复制这些发现,并扩大对长期结果的评估。
{"title":"Cognitive control circuit function predicts antidepressant outcomes: A signal detection approach to actionable clinical decisions","authors":"Leanne M. Williams ,&nbsp;Jerome Yesavage","doi":"10.1016/j.pmip.2024.100126","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100126","url":null,"abstract":"<div><h3>Background</h3><p>We previously identified a cognitive biotype of depression characterized by dysfunction of the brain’s cognitive control circuit, comprising the dorsolateral prefrontal cortex (dLPFC) and dorsal anterior cingulate cortex (dACC), derived from functional magnetic resonance imaging (fMRI). We evaluate these circuit metrics as personalized predictors of antidepressant remission.</p></div><div><h3>Methods</h3><p>We undertook a secondary analysis of data from the international Study to Predict Optimized Treatment in Depression (iSPOT-D) for 159 patients who completed fMRI during a GoNoGo task, 8 weeks treatment with one of three study antidepressants and who were assessed for remission status (Hamilton Depression Rating Scale score of ≤ 7). Circuit predictors of remission were dLPFC and dACC activity and connectivity quantified in standard deviations. Using established software implementing receiver operating analysis (ROC) we calculated the sensitivity and specificity of these predictors at every cut-point for every circuit measure. We calculated number needed to treat (NNT) metrics for the ROC model identifying optimal cut-point values.</p></div><div><h3>Results</h3><p>ROC models identified maximum separation of remitters (62.5%) from non-remitters (21.2%) at an initial cut-point of −0.75 standard deviations for dLPFC activity and averaged circuit metrics at secondary cutpoints. The NNT was 3.72, implying that if 4 patients (rounding of 3.72) were randomly selected, one would be likely to remit, but if circuit metrics informed treatment, two would be likely to remit.</p></div><div><h3>Conclusions</h3><p>Our findings contribute to identifying clinically actionable circuit measures for clinical trials and clinical practice. Future studies are needed to replicate these findings and expand the assessment of longer-term outcomes.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"45 ","pages":"Article 100126"},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140815886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Texas child mental health network: A child and adolescent research registry 得克萨斯州儿童精神健康网络:儿童和青少年研究登记处
Pub Date : 2024-04-13 DOI: 10.1016/j.pmip.2024.100124
Carol A. Tamminga , Madhukar H. Trivedi , Karen D. Wagner , Sarah Wakefield , D. Jeffrey Newport , James Norcross , David L. Lakey , Charles B. Nemeroff

The Texas Child Mental Health Care Consortium (TCMHCC) includes all twelve Health-Related Institutions (HRI) in the State of Texas. At each HRI, teams of child health faculty and staff are reviewing needs of children in Texas and providing new primary care interventions for children (eg, CPAN, TCHATT, CPWE). In addition to the clinical care programs, two research registries (for Trauma and Depression) have been developed to inform future care pathways with new data. The registries collect similar kinds of descriptive, medical and psychosocial data reliably. Because advances have suggested that events and experiences in early years could be the origins of adult mental health challenges, these research registries could contribute to the development and application of treatments during youth to mitigate both youth and adult manifestations of associated mental health vulnerabilities. These registries are set up and the members are reliably gathering baseline data throughout the state, which was the initial goal. The registries now include treatments, Trauma-CBT for Trauma and Behavioral Activation for Depression, to test for efficacy and specificity. We look forward to testing and comparing additional treatments in the future studies.

得克萨斯州儿童心理保健联合会(TCMHCC)包括得克萨斯州所有十二家与健康有关的机构(HRI)。各医疗机构的儿童健康教职员工团队正在审查得克萨斯州儿童的需求,并为儿童提供新的初级保健干预措施(如 CPAN、TCHATT、CPWE)。除临床护理计划外,还建立了两个研究登记处(创伤登记处和抑郁症登记处),以便利用新数据为未来的护理途径提供信息。这些登记处可靠地收集了类似的描述性、医疗和社会心理数据。由于研究进展表明,幼年时期的事件和经历可能是成年后心理健康挑战的起源,因此这些研究登记册有助于开发和应用青少年时期的治疗方法,以减轻青少年和成年后相关心理健康脆弱性的表现。这些登记处已经建立,其成员正在全州范围内可靠地收集基线数据,这也是最初的目标。现在,登记册包括了治疗创伤的创伤心理疗法和治疗抑郁症的行为激活疗法,以测试其疗效和特异性。我们期待在未来的研究中测试和比较更多的治疗方法。
{"title":"The Texas child mental health network: A child and adolescent research registry","authors":"Carol A. Tamminga ,&nbsp;Madhukar H. Trivedi ,&nbsp;Karen D. Wagner ,&nbsp;Sarah Wakefield ,&nbsp;D. Jeffrey Newport ,&nbsp;James Norcross ,&nbsp;David L. Lakey ,&nbsp;Charles B. Nemeroff","doi":"10.1016/j.pmip.2024.100124","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100124","url":null,"abstract":"<div><p>The Texas Child Mental Health Care Consortium (TCMHCC) includes all twelve Health-Related Institutions (HRI) in the State of Texas. At each HRI, teams of child health faculty and staff are reviewing needs of children in Texas and providing new primary care interventions for children (eg, CPAN, TCHATT, CPWE). In addition to the clinical care programs, two research registries (for Trauma and Depression) have been developed to inform future care pathways with new data. The registries collect similar kinds of descriptive, medical and psychosocial data reliably. Because advances have suggested that events and experiences in early years could be the origins of adult mental health challenges, these research registries could contribute to the development and application of treatments during youth to mitigate both youth and adult manifestations of associated mental health vulnerabilities. These registries are set up and the members are reliably gathering baseline data throughout the state, which was the initial goal. The registries now include treatments, Trauma-CBT for Trauma and Behavioral Activation for Depression, to test for efficacy and specificity. We look forward to testing and comparing additional treatments in the future studies.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"45 ","pages":"Article 100124"},"PeriodicalIF":0.0,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140549691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of machine learning and deep learning models in detecting depression on social media: A systematic literature review 使用机器学习和深度学习模型检测社交媒体上的抑郁症:系统性文献综述
Pub Date : 2024-04-05 DOI: 10.1016/j.pmip.2024.100125
Wadzani Aduwamai Gadzama, Danlami Gabi, Musa Sule Argungu, Hassan Umar Suru

Depression is regarded as one of the world's primary concerns. Recent researchers use artificial intelligence techniques like machine learning and deep learning to identify depressive symptoms automatically. This literature review focuses on using machine learning and deep learning models in depression detection on social media. Advances in deep learning have improved methods for identifying depression, which is one of the illnesses that affect the health of individuals. Some researchers employ a variety of deep-learning approaches to improve the diagnosis, detection, and prediction of depression to support expert decision-making. The researchers identified the available prediction techniques and tools used to detect, forecast, compare, and classify depression in victims systematically. Twenty-eight (28) articles relevant to machine learning and thirty-two (32) articles linked to deep learning were chosen and considered using boolean keyword searches in different publishing databases and filters. A significant number of the studies, according to the conclusions of the analysis, used machine learning techniques such as decision trees, K-nearest neighbours, naive bayes, random forests, and support vector machines. The deep learning models that are most frequently utilised include convolutional neural networks, long short-term memory, and recurrent neural networks with different datasets to detect subjects suffering from depression using social media data. The datasets used in these studies include Twitter, Facebook, Reddit, tweets from the Kaggle website, and clinic patients’ records. These datasets can include posts, comments, audio, video, images, and interviews. The results of this study revealed that, recently, several approaches have focused on using deep learning for depression detection. The paper highlighted that most research focuses on the detection and identification of depression. Prospects for cutting-edge studies in the detection of depression and other illnesses that are related to health were also suggested.

抑郁症被认为是世界上最令人担忧的问题之一。最近,研究人员使用机器学习和深度学习等人工智能技术来自动识别抑郁症状。这篇文献综述的重点是在社交媒体上使用机器学习和深度学习模型检测抑郁症。抑郁症是影响个人健康的疾病之一,深度学习的进步改进了识别抑郁症的方法。一些研究人员采用各种深度学习方法来改进抑郁症的诊断、检测和预测,以支持专家决策。研究人员系统地识别了用于检测、预测、比较和分类受害者抑郁症的现有预测技术和工具。通过在不同的出版数据库和过滤器中进行布尔关键词搜索,选择并考虑了与机器学习相关的二十八(28)篇文章和与深度学习相关的三十二(32)篇文章。根据分析结论,大量研究使用了机器学习技术,如决策树、K-近邻、奈夫贝叶斯、随机森林和支持向量机。最常用的深度学习模型包括卷积神经网络、长短期记忆和递归神经网络,这些模型使用不同的数据集,利用社交媒体数据检测抑郁症患者。这些研究中使用的数据集包括 Twitter、Facebook、Reddit、来自 Kaggle 网站的推文以及诊所患者的记录。这些数据集包括帖子、评论、音频、视频、图像和访谈。这项研究的结果表明,最近有几种方法侧重于使用深度学习进行抑郁检测。论文强调,大多数研究都集中在抑郁症的检测和识别上。论文还提出了在检测抑郁症和其他与健康有关的疾病方面的前沿研究前景。
{"title":"The use of machine learning and deep learning models in detecting depression on social media: A systematic literature review","authors":"Wadzani Aduwamai Gadzama,&nbsp;Danlami Gabi,&nbsp;Musa Sule Argungu,&nbsp;Hassan Umar Suru","doi":"10.1016/j.pmip.2024.100125","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100125","url":null,"abstract":"<div><p>Depression is regarded as one of the world's primary concerns. Recent researchers use artificial intelligence techniques like machine learning and deep learning to identify depressive symptoms automatically. This literature review focuses on using machine learning and deep learning models in depression detection on social media. Advances in deep learning have improved methods for identifying depression, which is one of the illnesses that affect the health of individuals. Some researchers employ a variety of deep-learning approaches to improve the diagnosis, detection, and prediction of depression to support expert decision-making. The researchers identified the available prediction techniques and tools used to detect, forecast, compare, and classify depression in victims systematically. Twenty-eight (28) articles relevant to machine learning and thirty-two (32) articles linked to deep learning were chosen and considered using boolean keyword searches in different publishing databases and filters. A significant number of the studies, according to the conclusions of the analysis, used machine learning techniques such as decision trees, K-nearest neighbours, naive bayes, random forests, and support vector machines. The deep learning models that are most frequently utilised include convolutional neural networks, long short-term memory, and recurrent neural networks with different datasets to detect subjects suffering from depression using social media data. The datasets used in these studies include Twitter, Facebook, Reddit, tweets from the Kaggle website, and clinic patients’ records. These datasets can include posts, comments, audio, video, images, and interviews. The results of this study revealed that, recently, several approaches have focused on using deep learning for depression detection. The paper highlighted that most research focuses on the detection and identification of depression. Prospects for cutting-edge studies in the detection of depression and other illnesses that are related to health were also suggested.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"45 ","pages":"Article 100125"},"PeriodicalIF":0.0,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140350895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The temporal dynamics of daily stress, affect, and several affect regulation processes, in patients with chronic mood and anxiety disorders before and after a mindful yoga intervention 正念瑜伽干预前后慢性情绪和焦虑症患者的日常压力、情感和几种情感调节过程的时间动态变化
Pub Date : 2024-03-19 DOI: 10.1016/j.pmip.2024.100123
Nina K. Vollbehr , Sanne H. Booij , H.J. Rogier Hoenders , Brian D. Ostafin , Agna A. Bartels-Velthuis

Background and Objectives

Patients with chronic mood and anxiety disorders experience many life stressors and are more reactive to these stressors. Although mindful yoga might reduce stress reactivity, little is known about the affect regulation mechanisms involved, such as repetitive negative thinking, fear of emotion, acting with awareness and body awareness.

Design and Methods

Using experience sampling methodology, 12 patients with chronic mood and anxiety disorders completed five daily assessments for 15 days before and after a 9-week mindful yoga intervention. Interrupted time-series analyses were used to assess mean-level change from pre-to-post intervention and vector autoregressive models to assess change in the temporal associations.

Results

Most individuals experienced positive changes in affect and the proposed affect regulation processes. Fear of emotion showed changes from pre-to-post intervention for most individuals (67%), followed by acting with awareness (58%), body awareness (58%) and repetitive negative thinking (50%). In the dynamic relationships between stressors, the four affect regulation processes and affect, there were individual differences in which pathways changed and how they changed.

Conclusions

After a mindful yoga intervention, affect and several affect regulation processes improve in most individuals. Achieving this in the context of daily life stress, seems to be more complicated.

Trial registration

ISRCTN register (study ID ISRCTN13612864).

背景和目的慢性情绪和焦虑症患者会经历许多生活压力,并且对这些压力的反应更加强烈。尽管正念瑜伽可能会降低压力反应性,但人们对其中涉及的情感调节机制知之甚少,如重复性负面思维、对情感的恐惧、意识行动和身体意识。设计与方法采用经验抽样方法,12 名慢性情绪和焦虑症患者在为期 9 周的正念瑜伽干预前后 15 天内完成了五次日常评估。使用间断时间序列分析评估干预前后的平均水平变化,并使用向量自回归模型评估时间关联的变化。从干预前到干预后,大多数人对情绪的恐惧发生了变化(67%),其次是意识行动(58%)、身体意识(58%)和重复负面思维(50%)。在压力源、四种情感调节过程和情感之间的动态关系中,哪些途径发生了变化以及如何变化存在个体差异。试验注册ISRCTN注册(研究编号ISRCTN13612864)。
{"title":"The temporal dynamics of daily stress, affect, and several affect regulation processes, in patients with chronic mood and anxiety disorders before and after a mindful yoga intervention","authors":"Nina K. Vollbehr ,&nbsp;Sanne H. Booij ,&nbsp;H.J. Rogier Hoenders ,&nbsp;Brian D. Ostafin ,&nbsp;Agna A. Bartels-Velthuis","doi":"10.1016/j.pmip.2024.100123","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100123","url":null,"abstract":"<div><h3>Background and Objectives</h3><p>Patients with chronic mood and anxiety disorders experience many life stressors and are more reactive to these stressors. Although mindful yoga might reduce stress reactivity, little is known about the affect regulation mechanisms involved, such as repetitive negative thinking, fear of emotion, acting with awareness and body awareness.</p></div><div><h3>Design and Methods</h3><p>Using experience sampling methodology, 12 patients with chronic mood and anxiety disorders completed five daily assessments for 15 days before and after a 9-week mindful yoga intervention. Interrupted time-series analyses were used to assess mean-level change from pre-to-post intervention and vector autoregressive models to assess change in the temporal associations.</p></div><div><h3>Results</h3><p>Most individuals experienced positive changes in affect and the proposed affect regulation processes. Fear of emotion showed changes from pre-to-post intervention for most individuals (67%), followed by acting with awareness (58%), body awareness (58%) and repetitive negative thinking (50%). In the dynamic relationships between stressors, the four affect regulation processes and affect, there were individual differences in which pathways changed and how they changed.</p></div><div><h3>Conclusions</h3><p>After a mindful yoga intervention, affect and several affect regulation processes improve in most individuals. Achieving this in the context of daily life stress, seems to be more complicated.</p></div><div><h3>Trial registration</h3><p>ISRCTN register (study ID ISRCTN13612864).</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"45 ","pages":"Article 100123"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468171724000097/pdfft?md5=fb4c1bc27d688a2f20c3b5f1843121c0&pid=1-s2.0-S2468171724000097-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140163803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression 耐药性抑郁症患者的终生童年逆境史和药物滥用史
Pub Date : 2024-03-01 DOI: 10.1016/j.pmip.2024.100122
Eugenia Giampetruzzi, William McDonald, Hanna Rice, Brandon M. Kitay, Adriana P. Hermida, Patricio Riva Posse, Rachel Hershenberg

Both adverse childhood experiences (ACEs) and substance abuse have shown individual associations with treatment-resistant depression (TRD). Yet, limited research has explored the joint association of ACEs and substance abuse in TRD patients. This study aimed to evaluate how the amount and type of ACE exposure increase the risk of lifetime substance abuse in a clinical sample of 725 outpatients diagnosed with major depressive disorder (MDD) or persistent depressive disorder.

Logistic regression analyses were used to assess whether heightened ACE exposure increased the risk of substance abuse, and to examine the relationship between five ACE subtypes (e.g., sexual abuse (CSA), physical violence, injury/illness, childhood grief, and parental upheaval) and history of substance abuse.

Greater ACE exposure increased risk of substance abuse. CSA independently predicted a history of substance abuse. This provides further evidence for the additive effects of ACEs and that CSA may have a unique link to substance abuse.

不良童年经历(ACE)和药物滥用都显示出与治疗耐受性抑郁症(TRD)的个体关联。然而,对于ACE和药物滥用在TRD患者中的共同关联性的研究还很有限。本研究旨在对 725 名被诊断为重度抑郁障碍(MDD)或持续性抑郁障碍的门诊患者进行临床抽样调查,以评估 ACE 暴露的数量和类型会如何增加终生药物滥用的风险、性虐待 (CSA)、身体暴力、伤害/疾病、童年悲伤和父母动荡)与药物滥用史之间的关系。CSA 可独立预测药物滥用史。这进一步证明了ACE的叠加效应,以及CSA可能与药物滥用有着独特的联系。
{"title":"Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression","authors":"Eugenia Giampetruzzi,&nbsp;William McDonald,&nbsp;Hanna Rice,&nbsp;Brandon M. Kitay,&nbsp;Adriana P. Hermida,&nbsp;Patricio Riva Posse,&nbsp;Rachel Hershenberg","doi":"10.1016/j.pmip.2024.100122","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100122","url":null,"abstract":"<div><p>Both adverse childhood experiences (ACEs) and substance abuse have shown individual associations with treatment-resistant depression (TRD). Yet, limited research has explored the joint association of ACEs and substance abuse in TRD patients. This study aimed to evaluate how the amount and type of ACE exposure increase the risk of lifetime substance abuse in a clinical sample of 725 outpatients diagnosed with major depressive disorder (MDD) or persistent depressive disorder.</p><p>Logistic regression analyses were used to assess whether heightened ACE exposure increased the risk of substance abuse, and to examine the relationship between five ACE subtypes (e.g., sexual abuse (CSA), physical violence, injury/illness, childhood grief, and parental upheaval) and history of substance abuse.</p><p>Greater ACE exposure increased risk of substance abuse. CSA independently predicted a history of substance abuse. This provides further evidence for the additive effects of ACEs and that CSA may have a unique link to substance abuse.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100122"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140066696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The multi-modal treatment of catatonia: Targeting multiple receptors when GABA-based benzodiazepines fail 紧张症的多模式治疗:当基于 GABA 的苯并二氮杂卓失效时瞄准多种受体
Pub Date : 2024-03-01 DOI: 10.1016/j.pmip.2024.100121
Nikhila Veluri , William Wise , Roberto Kutcher , Silvina Tonarelli , Martin Guerrero

The family brought a 48-year-old woman with major depressive disorder to the emergency room due to unresponsiveness and bizarre behavior. Catatonia was suspected and confirmed by a positive lorazepam challenge test. The patient’s home regimen included bupropion, though the family reported non-adherence. Intravenous lorazepam was scheduled, and the patient’s catatonic symptoms gradually improved. Gradual tapering of lorazepam caused the re-appearance of catatonic symptoms. Each attempt at tapering lorazepam resulted in catatonic symptoms resurfacing and requiring higher scheduled doses of lorazepam. Electroconvulsive treatment was not an option as (1) it was not easily accessible, and (2) the patient did not consent. Multiple anti-depressants were tried and discontinued due to intolerable side effects, and the patient eventually partially improved with mirtazapine, zolpidem, memantine, and lorazepam. Catatonia is a complex neuropsychiatric syndrome that requires prompt recognition, diagnosis, and treatment. Such cases pose a challenge to physicians. Our case emphasizes considering the uniqueness of each individual’s presentation of chronic catatonia during treatment.

一名患有重度抑郁症的 48 岁女性因反应迟钝和行为怪异被家人送到急诊室。家人怀疑患者患有紧张症,并通过劳拉西泮挑战试验证实了这一点。患者的家庭治疗方案中包括安非他酮,但其家人表示没有坚持治疗。患者被安排静脉注射劳拉西泮,其紧张性症状逐渐得到改善。逐渐减量劳拉西泮会导致紧张性症状再次出现。每次尝试减少劳拉西泮的剂量,都会导致紧张性症状再次出现,需要按计划增加劳拉西泮的剂量。电休克治疗不可行,因为(1)不容易获得,(2)病人不同意。患者尝试了多种抗抑郁药物,但都因无法忍受的副作用而停药,最终在服用米氮平、唑吡坦、美金刚和劳拉西泮后病情得到部分改善。紧张症是一种复杂的神经精神综合征,需要及时识别、诊断和治疗。这类病例给医生带来了挑战。我们的病例强调在治疗过程中要考虑到每个人的慢性紧张症表现的独特性。
{"title":"The multi-modal treatment of catatonia: Targeting multiple receptors when GABA-based benzodiazepines fail","authors":"Nikhila Veluri ,&nbsp;William Wise ,&nbsp;Roberto Kutcher ,&nbsp;Silvina Tonarelli ,&nbsp;Martin Guerrero","doi":"10.1016/j.pmip.2024.100121","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100121","url":null,"abstract":"<div><p>The family brought a 48-year-old woman with major depressive disorder to the emergency room due to unresponsiveness and bizarre behavior. Catatonia was suspected and confirmed by a positive lorazepam challenge test. The patient’s home regimen included bupropion, though the family reported non-adherence. Intravenous lorazepam was scheduled, and the patient’s catatonic symptoms gradually improved. Gradual tapering of lorazepam caused the re-appearance of catatonic symptoms. Each attempt at tapering lorazepam resulted in catatonic symptoms resurfacing and requiring higher scheduled doses of lorazepam. Electroconvulsive treatment was not an option as (1) it was not easily accessible, and (2) the patient did not consent. Multiple anti-depressants were tried and discontinued due to intolerable side effects, and the patient eventually partially improved with mirtazapine, zolpidem, memantine, and lorazepam. Catatonia is a complex neuropsychiatric syndrome that requires prompt recognition, diagnosis, and treatment. Such cases pose a challenge to physicians. Our case emphasizes considering the uniqueness of each individual’s presentation of chronic catatonia during treatment.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100121"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression 住院治疗难治性抑郁症患者对鼻内氯胺酮反应的预测因素
Pub Date : 2024-02-24 DOI: 10.1016/j.pmip.2024.100119
Evyn M. Peters , Katelyn Halpape , Isaac Cheveldae , Patrick Jacobson , Annabelle Wanson

Background

Ketamine is recognized as an effective treatment for major depressive disorder but there remains a need to identify predictors of response to ketamine therapy.

Methods

This naturalistic study was a retrospective analysis of data from 48 patients with treatment-resistant depression who received up to four doses of intranasal ketamine in an acute psychiatric hospital setting. Baseline demographic and clinical variables were examined as potential predictors of response along with treatment-emergent dissociation and blood pressure changes. Response was defined as a depression score decrease of 50% or more from baseline measured with the Hamilton Depression Rating Scale or the Montgomery–Åsberg Depression Rating Scale.

Results

The response rate was significantly lower in patients diagnosed with a personality disorder, the most common of which was borderline personality disorder. In contrast, baseline scores on patient-reported questionnaires assessing maladaptive personality traits were not associated with lower response rates. Adverse childhood experiences and dissociation during treatment were associated with higher response rates.

Conclusions

Patients with significant childhood trauma appeared to benefit more from ketamine treatment, consistent with previous research. More research to determine if personality disorders influence ketamine response is needed and should distinguish clinical diagnoses from those derived solely from patient-reported questionnaires. Treatment-emergent dissociation could be a predictor of response to intranasal ketamine but requires further study.

背景氯胺酮被认为是治疗重度抑郁障碍的有效方法,但仍有必要确定氯胺酮治疗反应的预测因素。方法这项自然研究是一项回顾性数据分析,研究对象是在一家急诊精神病院接受了最多四次氯胺酮鼻内注射的 48 名难治性抑郁症患者。研究人员对基线人口统计学和临床变量以及治疗引起的解离和血压变化进行了研究,将其作为反应的潜在预测因素。采用汉密尔顿抑郁评定量表或蒙哥马利-阿斯伯格抑郁评定量表进行测量,抑郁评分比基线下降 50% 或以上即为应答。相比之下,评估适应不良人格特质的患者报告问卷的基线得分与较低的应答率无关。结论有严重童年创伤的患者似乎更容易从氯胺酮治疗中获益,这与之前的研究结果一致。需要进行更多研究来确定人格障碍是否会影响氯胺酮反应,并应将临床诊断与仅根据患者报告问卷得出的诊断区分开来。治疗中出现的分离可能是对鼻内氯胺酮反应的一个预测因素,但还需要进一步研究。
{"title":"Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression","authors":"Evyn M. Peters ,&nbsp;Katelyn Halpape ,&nbsp;Isaac Cheveldae ,&nbsp;Patrick Jacobson ,&nbsp;Annabelle Wanson","doi":"10.1016/j.pmip.2024.100119","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100119","url":null,"abstract":"<div><h3>Background</h3><p>Ketamine is recognized as an effective treatment for major depressive disorder but there remains a need to identify predictors of response to ketamine therapy.</p></div><div><h3>Methods</h3><p>This naturalistic study was a retrospective analysis of data from 48 patients with treatment-resistant depression who received up to four doses of intranasal ketamine in an acute psychiatric hospital setting. Baseline demographic and clinical variables were examined as potential predictors of response along with treatment-emergent dissociation and blood pressure changes. Response was defined as a depression score decrease of 50% or more from baseline measured with the Hamilton Depression Rating Scale or the Montgomery–Åsberg Depression Rating Scale.</p></div><div><h3>Results</h3><p>The response rate was significantly lower in patients diagnosed with a personality disorder, the most common of which was borderline personality disorder. In contrast, baseline scores on patient-reported questionnaires assessing maladaptive personality traits were not associated with lower response rates. Adverse childhood experiences and dissociation during treatment were associated with higher response rates.</p></div><div><h3>Conclusions</h3><p>Patients with significant childhood trauma appeared to benefit more from ketamine treatment, consistent with previous research. More research to determine if personality disorders influence ketamine response is needed and should distinguish clinical diagnoses from those derived solely from patient-reported questionnaires. Treatment-emergent dissociation could be a predictor of response to intranasal ketamine but requires further study.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100119"},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139945064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and psychosocial factors affecting outcome with sublingual buprenorphine-naloxone substitution in opioid dependence in terms of abstinence and compliance-A two years longitudinal study 影响丁丙诺啡-纳洛酮舌下替代治疗阿片类药物依赖在戒断和依从性方面效果的临床和社会心理因素--一项为期两年的纵向研究
Pub Date : 2024-02-20 DOI: 10.1016/j.pmip.2024.100120
Sourav Das , Sreetama Chatterjee , Aniket Mukherjee , Divyashree Sah

Background

Sublingual buprenorphine-naloxone combination is effective and safe as maintenance therapy in opioid dependence but there is little data to choose the right candidates based on clinical and sociodemographic profiles, often leading to poorer outcomes and relapse. Our study aims to aid clinicians in selecting appropriate candidates for such therapy.

Methods

We conducted a prospective observational study on 106 Opioid-dependent subjects over 5 years where each subject was followed up for 2 years. Sociodemographic profiles, opioid dependence severity, buprenorphine-naloxone dose needed, age at treatment onset, duration of opioid dependence, presence of comorbid Axis I, Axis II disorders, other substance use, and other relevant factors were measured.

Results

Most of the subjects were young adult males with severe dependence. Only 17% remained non-compliant while 18.87% relapsed completely. Buprenorphine-naloxone dose needed was significantly correlated with the severity of dependence. Good compliance with buprenorphine-naloxone predicted less relapse to opioids. Higher buprenorphine-naloxone dose, financial stability, employment and not having problems with primary support group predicted more compliance and abstinence. Being graduate, coexisting mood or anxiety disorders predicted better compliance. Comorbid Axis II disorders, benzodiazepine, or cannabis dependence predicted higher relapse. Ironically, having high perceived criticism was found to be protective against relapse.

Conclusion

Buprenorphine-naloxone therapy has a high rate of long-term compliance even with severe opioid dependence with a relapse rate of less than one in five subjects. Compliance is the biggest predictor of abstinence offering excellent protection against relapse, particularly with optimum dosing of Buprenorphine-naloxone, employment, financial stability, and supportive family.

背景舌下丁丙诺啡-纳洛酮复方制剂作为阿片类药物依赖的维持疗法既有效又安全,但根据临床和社会人口学特征选择合适人选的数据却很少,这往往会导致较差的疗效和复发。我们的研究旨在帮助临床医生选择接受此类治疗的合适人选。方法我们对 106 名阿片类药物依赖者进行了一项为期 5 年的前瞻性观察研究,并对每位受试者进行了为期 2 年的随访。对社会人口学特征、阿片类药物依赖严重程度、所需丁丙诺啡-纳洛酮剂量、开始治疗时的年龄、阿片类药物依赖持续时间、是否合并轴I、轴II障碍、其他药物使用以及其他相关因素进行了测量。只有 17% 的受试者仍未遵从医嘱,而 18.87% 的受试者则完全复吸。丁丙诺啡-纳洛酮所需剂量与依赖的严重程度显著相关。丁丙诺啡-纳洛酮依从性好,则阿片类药物复吸率低。较高的丁丙诺啡-纳洛酮剂量、经济稳定、就业以及与主要支持群体没有问题,都预示着更高的依从性和戒断率。如果是毕业生,同时患有情绪或焦虑症,则依从性会更好。合并轴 II 疾病、苯二氮卓类药物或大麻依赖则预示着更高的复发率。具有讽刺意味的是,人们发现高感知批评对复发具有保护作用。结论丁丙诺啡-纳洛酮疗法的长期依从性很高,即使是严重阿片类药物依赖者,复发率也低于五分之一。依从性是戒断的最大预测因素,可有效防止复发,尤其是在最佳丁丙诺啡-纳洛酮剂量、就业、经济稳定和家庭支持的情况下。
{"title":"Clinical and psychosocial factors affecting outcome with sublingual buprenorphine-naloxone substitution in opioid dependence in terms of abstinence and compliance-A two years longitudinal study","authors":"Sourav Das ,&nbsp;Sreetama Chatterjee ,&nbsp;Aniket Mukherjee ,&nbsp;Divyashree Sah","doi":"10.1016/j.pmip.2024.100120","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100120","url":null,"abstract":"<div><h3>Background</h3><p>Sublingual buprenorphine-naloxone combination is effective and safe as maintenance therapy in opioid dependence but there is little data to choose the right candidates based on clinical and sociodemographic profiles, often leading to poorer outcomes and relapse. Our study aims to aid clinicians in selecting appropriate candidates for such therapy.</p></div><div><h3>Methods</h3><p>We conducted a prospective observational study on 106 Opioid-dependent subjects over 5 years where each subject was followed up for 2 years. Sociodemographic profiles, opioid dependence severity, buprenorphine-naloxone dose needed, age at treatment onset, duration of opioid dependence, presence of comorbid Axis I, Axis II disorders, other substance use, and other relevant factors were measured.</p></div><div><h3>Results</h3><p>Most of the subjects were young adult males with severe dependence. Only 17% remained non-compliant while 18.87% relapsed completely. Buprenorphine-naloxone dose needed was significantly correlated with the severity of dependence. Good compliance with buprenorphine-naloxone predicted less relapse to opioids. Higher buprenorphine-naloxone dose, financial stability, employment and not having problems with primary support group predicted more compliance and abstinence. Being graduate, coexisting mood or anxiety disorders predicted better compliance. Comorbid Axis II disorders, benzodiazepine, or cannabis dependence predicted higher relapse. Ironically, having high perceived criticism was found to be protective against relapse.</p></div><div><h3>Conclusion</h3><p>Buprenorphine-naloxone therapy has a high rate of long-term compliance even with severe opioid dependence with a relapse rate of less than one in five subjects. Compliance is the biggest predictor of abstinence offering excellent protection against relapse, particularly with optimum dosing of Buprenorphine-naloxone, employment, financial stability, and supportive family.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100120"},"PeriodicalIF":0.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139914595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental health of young researchers in academia: Towards to growth perspective 学术界青年研究人员的心理健康:从成长角度看问题
Pub Date : 2024-02-01 DOI: 10.1016/j.pmip.2024.100116
Dina Di Giacomo , Eleonora Cilli , Jessica Ranieri , Federica Guerra , Alessandra Martelli

Objective

Young Researchers are a strategic sector in the research community because of the future academic scholars. Recently, growing evidence suggests mental health of young generation of researchers has a significant impact on their wellness, as well the related research output and their future career development. This study aimed to contribute and exploit a conceptual framework self-determination theory tailored to the academic context considering the specifics and challenges of academia.

Methods

Participants were 134 young Early Career Academics (mean age = 30.6; SD = 4.38; range = 25–40 years) enrolled via institutional e-mail. Psychological assessment was conducted applying standardized tests evaluating depression, anxiety, stress, emotional regulation difficulties and grit trait.

Results

Our findings highlighted a general trend toward negative psychological dimensions in young researchers: PhD students and Research contracts showed signs of depression, anxiety and stress. More, they highlighted reduced positive outcomes in psychological dimensions, as well as lower ability to manage emotional experiences and then to be perseverant for long-term goals and motivation. The balancing among examined psychological dimensions represents the perspective for mental health actions towards to personal growth related to successful academia experience.

Conclusions

Policy changes, communication activities and health-promotion activities through the circulation of experience, sharing actions, and strategies could be the pillar for fostering healthy academics by raising awareness, implementing interventions, or engaging professionals concerning mental health in academia.

目标青年研究人员是研究界的一个战略部门,因为他们是未来的学术学者。最近,越来越多的证据表明,年轻一代研究人员的心理健康对他们的健康、相关研究成果和未来职业发展有着重要影响。考虑到学术界的特殊性和挑战,本研究旨在为学术界量身定制一个自我决定理论概念框架,并对其加以利用。心理评估采用标准化测试,评估抑郁、焦虑、压力、情绪调节困难和勇气特质:我们的研究结果表明,年轻研究人员的心理普遍趋于消极:博士生和研究合同人员表现出抑郁、焦虑和压力。此外,他们在心理维度上的积极结果也有所减少,管理情绪体验的能力也有所降低,对长期目标和动机的坚持也有所减弱。结论通过交流经验、分享行动和策略来改变政策、开展交流活动和健康促进活动,可以提高人们对学术界心理健康的认识、实施干预措施或让专业人员参与进来,从而成为促进学术界健康发展的支柱。
{"title":"Mental health of young researchers in academia: Towards to growth perspective","authors":"Dina Di Giacomo ,&nbsp;Eleonora Cilli ,&nbsp;Jessica Ranieri ,&nbsp;Federica Guerra ,&nbsp;Alessandra Martelli","doi":"10.1016/j.pmip.2024.100116","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100116","url":null,"abstract":"<div><h3>Objective</h3><p>Young Researchers are a strategic sector in the research community because of the future academic scholars. Recently, growing evidence suggests mental health of young generation of researchers has a significant impact on their wellness, as well the related research output and their future career development. This study aimed to contribute and exploit a conceptual framework self-determination theory tailored to the academic context considering the specifics and challenges of academia.</p></div><div><h3>Methods</h3><p>Participants were 134 young Early Career Academics (mean age = 30.6; SD = 4.38; range = 25–40 years) enrolled via institutional e-mail. Psychological assessment was conducted applying standardized tests evaluating depression, anxiety, stress, emotional regulation difficulties and grit trait.</p></div><div><h3>Results</h3><p>Our findings highlighted a general trend toward negative psychological dimensions in young researchers: PhD students and Research contracts showed signs of depression, anxiety and stress. More, they highlighted reduced positive outcomes in psychological dimensions, as well as lower ability to manage emotional experiences and then to be perseverant for long-term goals and motivation. The balancing among examined psychological dimensions represents the perspective for mental health actions towards to personal growth related to successful academia experience.</p></div><div><h3>Conclusions</h3><p>Policy changes, communication activities and health-promotion activities through the circulation of experience, sharing actions, and strategies could be the pillar for fostering healthy academics by raising awareness, implementing interventions, or engaging professionals concerning mental health in academia.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100116"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468171724000024/pdfft?md5=97b5a88a54b6011ff5620324010478a8&pid=1-s2.0-S2468171724000024-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ten-year patterns of psychiatric medications dispensed to adolescent in Finland: Open dialogue-informed practice in Western Lapland as compared to practice in other Finnish regions 芬兰青少年精神科用药的十年模式:西拉普兰与芬兰其他地区的公开对话实践比较
Pub Date : 2024-02-01 DOI: 10.1016/j.pmip.2024.100117
Kari Valtanen , Jaakko Seikkula , Mia Kurtti , Jouko Miettunen , Tomi Bergström

The iatrogenic risks of long-term psychotropic treatment can be minimized by reducing the amount of medication prescribed, which may be a factor in the promising outcomes of need-adapted treatment strategies such as the Open Dialogue (OD) approach. However, there is no comparison between long-term psychotropic treatment patterns in adolescents under OD-based and standard psychiatric care. This longitudinal register-based cohort study study aimed to describe the long-term medication patterns in Finland for all adolescents aged 13–20 receiving first-time psychiatric treatment from 2003 to 2008 (N = 44,685). Adolescents treated in other parts of Finland (n = 44,088) were compared to those in the Western Lapland catchment area (n = 780), where OD covered the entire mental healthcare service. Data on medication dispensation from the start of treatment until the 10-year follow-up or death were analyzed.

Adolescents who started treatment outside OD were more likely to be dispensed antipsychotics (aOR: 2.4, 95 %CI: 1.9–2.9), antidepressants (aOR: 1.8, 95 %CI: 1.5–2), and benzodiazepines (aOR: 2.4, 95 %CI: 1.9–3). The proportion of those receiving antipsychotics and antidepressants remained stable, with a slight increase in the OD group. Both groups showed an increasing percentage of benzodiazepine and stimulant use in the final follow-up years. Most drug treatment periods lasted less than two years. Under OD, adolescents had lower cumulative medication exposure, suggesting lower dosages than standard care.

Organizing mental health services based on OD may reduce psychotropic treatment in young people, but further research is needed to assess its clinical significance.

长期精神药物治疗的先天性风险可以通过减少处方用药量降至最低,这可能是开放式对话(OD)方法等适应需求的治疗策略取得良好疗效的一个因素。然而,目前还没有基于开放式对话的青少年长期精神药物治疗模式与标准精神治疗模式之间的比较。这项以登记为基础的纵向队列研究旨在描述2003年至2008年期间芬兰所有首次接受精神病治疗的13至20岁青少年的长期用药模式(N = 44,685)。在芬兰其他地区接受治疗的青少年(n = 44,088)与在西拉普兰集水区接受治疗的青少年(n = 780)进行了比较,后者的OD覆盖了整个精神医疗服务。在OD以外地区开始治疗的青少年更有可能获得抗精神病药物(aOR:2.4,95%CI:1.9-2.9)、抗抑郁药物(aOR:1.8,95%CI:1.5-2)和苯二氮卓类药物(aOR:2.4,95%CI:1.9-3)。接受抗精神病药物和抗抑郁药物治疗的比例保持稳定,OD 组略有增加。在最后几年的随访中,两组使用苯二氮卓和兴奋剂的比例均有所上升。大多数药物治疗持续时间不到两年。在OD模式下,青少年的累积用药量较低,这表明其用药量低于标准护理。根据OD模式组织心理健康服务可能会减少青少年的精神药物治疗,但还需要进一步的研究来评估其临床意义。
{"title":"Ten-year patterns of psychiatric medications dispensed to adolescent in Finland: Open dialogue-informed practice in Western Lapland as compared to practice in other Finnish regions","authors":"Kari Valtanen ,&nbsp;Jaakko Seikkula ,&nbsp;Mia Kurtti ,&nbsp;Jouko Miettunen ,&nbsp;Tomi Bergström","doi":"10.1016/j.pmip.2024.100117","DOIUrl":"https://doi.org/10.1016/j.pmip.2024.100117","url":null,"abstract":"<div><p>The iatrogenic risks of long-term psychotropic treatment<span><span><span> can be minimized by reducing the amount of medication prescribed, which may be a factor in the promising outcomes of need-adapted treatment strategies such as the Open Dialogue (OD) approach. However, there is no comparison between long-term psychotropic treatment patterns in adolescents under OD-based and standard psychiatric care. This longitudinal register-based </span>cohort study study aimed to describe the long-term medication patterns in Finland for all adolescents aged 13–20 receiving first-time </span>psychiatric treatment from 2003 to 2008 (N = 44,685). Adolescents treated in other parts of Finland (n = 44,088) were compared to those in the Western Lapland catchment area (n = 780), where OD covered the entire mental healthcare service. Data on medication dispensation from the start of treatment until the 10-year follow-up or death were analyzed.</span></p><p><span>Adolescents who started treatment outside OD were more likely to be dispensed antipsychotics (aOR: 2.4, 95 %CI: 1.9–2.9), antidepressants (aOR: 1.8, 95 %CI: 1.5–2), and </span>benzodiazepines<span> (aOR: 2.4, 95 %CI: 1.9–3). The proportion of those receiving antipsychotics and antidepressants remained stable, with a slight increase in the OD group. Both groups showed an increasing percentage of benzodiazepine and stimulant use in the final follow-up years. Most drug treatment periods lasted less than two years. Under OD, adolescents had lower cumulative medication exposure, suggesting lower dosages than standard care.</span></p><p>Organizing mental health services based on OD may reduce psychotropic treatment in young people, but further research is needed to assess its clinical significance.</p></div>","PeriodicalId":19837,"journal":{"name":"Personalized Medicine in Psychiatry","volume":"43 ","pages":"Article 100117"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139674722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Personalized Medicine in Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1